Action Cullinan Therapeutics - CGEM

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

9,65

Prix Achat

9,64

Prix Vente

9,67

Volume échangé

281 879

9,605 Fourchette du Jour 11,31

9,55 Plage de 52 semaines 30,1886

Cap du marché

561,896M

Clôture Veille

11,04

Ouverture

11,19

Dernière Transaction

9.65

Dernière heure de transaction

20:42:37

Volume financier

US$ 2 971 678

VWAP

10,5424

Volume moyen (3 m)

540 377

Actions en circulation

58 227 593

Rendement du Dividende

Ratio Cours sur Bénéfices

-3,74

Bénéfice par action (BPA)

-2,63

Chiffre d'affairess

Bénéfice net

-153,16M

Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients. Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.

Secteur

Biological Pds,ex Diagnstics

Industrie

Biological Pds,ex Diagnstics

Site Web

www.cullinantherapeutics.com

Siège social

Wilmington, Delaware, USA

Fondé

Cullinan Therapeutics Inc est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker CGEM. Le dernier cours de clôture d'Cullinan Therapeutics était de US$11,04. Au cours de la dernière année, les actions de Cullinan Therapeutics ont été négociées dans une fourchette de prix de US$ 9,55 à US$ 30,1886.

Cullinan Therapeutics compte actuellement 58 227 593 actions en circulation. La capitalisation boursière d'Cullinan Therapeutics est de US$642,83 million. Cullinan Therapeutics a un ratio cours/bénéfice (ratio PE) de -3.74.

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Cullinan Therapeutics Announces Preclinical Data for CLN-978, a CD19-directed T Cell Engager, to be Presented at ACR Convergence 2024

Cullinan will present new in vitro preclinical data that provide further strong rationale for broad clinical development of CLN-978 in autoimmune diseases Cullinan will share details of global...

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form 4 - Statement of changes in beneficial ownership of securities

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-2.155	-18.2549767048	11.805	12.16	9.55	665937	11.19524114	CS
4	-2.095	-17.8373776075	11.745	12.985	9.55	618741	11.72290445	CS
12	-6.34	-39.6497811132	15.99	17.5034	9.55	540377	13.37026439	CS
26	-7.08	-42.3191870891	16.73	21.01	9.55	582653	15.98619752	CS
52	-0.85	-8.09523809524	10.5	30.1886	9.55	651241	18.18366793	CS
156	-3.46	-26.3920671243	13.11	30.1886	7.3	383882	15.11294071	CS
260	-32.35	-77.0238095238	42	59.85	7.3	354368	17.79645997	CS

CGEM - Frequently Asked Questions (FAQ)

What is the current Cullinan Therapeutics share price?

The current share price of Cullinan Therapeutics is US$ 9,65

How many Cullinan Therapeutics shares are in issue?

Cullinan Therapeutics has 58 227 593 shares in issue

What is the market cap of Cullinan Therapeutics?

The market capitalisation of Cullinan Therapeutics is USD 642,83M

What is the 1 year trading range for Cullinan Therapeutics share price?

Cullinan Therapeutics has traded in the range of US$ 9,55 to US$ 30,1886 during the past year

What is the PE ratio of Cullinan Therapeutics?

The price to earnings ratio of Cullinan Therapeutics is -3,74

What is the reporting currency for Cullinan Therapeutics?

Cullinan Therapeutics reports financial results in USD

What is the latest annual profit for Cullinan Therapeutics?

The latest annual profit of Cullinan Therapeutics is USD -153,16M

What is the registered address of Cullinan Therapeutics?

The registered address for Cullinan Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801

What is the Cullinan Therapeutics website address?

The website address for Cullinan Therapeutics is www.cullinantherapeutics.com

Which industry sector does Cullinan Therapeutics operate in?

Cullinan Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
HEESH and E Equipment Services Inc	US$ 90,32 (105,55%)	11,3M
AIFFFirefly Neuroscience Inc	US$ 3,24 (70,53%)	120,83M
ERNAEterna Therapeutics Inc	US$ 0,525 (69,90%)	547,78M
TDUPThredUp Inc	US$ 1,87 (43,85%)	12,51M
NMHINatures Miracle Holding Inc	US$ 1,61 (42,48%)	159,13M
PHIOPhio Pharmaceuticals Corporation	US$ 3,36 (-49,09%)	10,3M
MBIOMustang Bio Inc	US$ 0,1427 (-36,27%)	13,95M
AEHRAehr Test Systems	US$ 11,68 (-26,95%)	4,67M
SLRXSalarius Pharmaceuticals Inc	US$ 2,71 (-26,16%)	1,63M
ATPCAgape ATP Corporation	US$ 1,47 (-25,38%)	1,09M
ERNAEterna Therapeutics Inc	US$ 0,5216 (68,80%)	547,81M
RGTIRigetti Computing Inc	US$ 8,5491 (41,31%)	284,16M
NMHINatures Miracle Holding Inc	US$ 1,6074 (42,25%)	159,14M
GCTKGlucoTrack Inc	US$ 0,1244 (-16,90%)	156,51M
NVDANVIDIA Corporation	US$ 131,85 (-1,04%)	142,79M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Cullinan Therapeutics Inc (CGEM) Cours

Cullinan Therapeutics Inc (CGEM)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de Cullinan Therapeutics Inc

CGEM Dernières nouvelles

CGEM - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application